WO2003004531A3 - Regulation d'une proteine du type recepteur de la somatostatine humaine - Google Patents
Regulation d'une proteine du type recepteur de la somatostatine humaine Download PDFInfo
- Publication number
- WO2003004531A3 WO2003004531A3 PCT/EP2002/007564 EP0207564W WO03004531A3 WO 2003004531 A3 WO2003004531 A3 WO 2003004531A3 EP 0207564 W EP0207564 W EP 0207564W WO 03004531 A3 WO03004531 A3 WO 03004531A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- somatostatin receptor
- human somatostatin
- regulation
- reagents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/655—Somatostatins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPPCT/EP01/07737 | 2001-07-06 | ||
PCT/EP2001/007737 WO2003004530A1 (fr) | 2001-07-06 | 2001-07-06 | Régulation de la protéine semblable à un récepteur de la somatostatine humaine |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003004531A2 WO2003004531A2 (fr) | 2003-01-16 |
WO2003004531A3 true WO2003004531A3 (fr) | 2003-12-04 |
Family
ID=8164490
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/007737 WO2003004530A1 (fr) | 2001-07-06 | 2001-07-06 | Régulation de la protéine semblable à un récepteur de la somatostatine humaine |
PCT/EP2002/007564 WO2003004531A2 (fr) | 2001-07-06 | 2002-07-08 | Regulation d'une proteine du type recepteur de la somatostatine humaine |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/007737 WO2003004530A1 (fr) | 2001-07-06 | 2001-07-06 | Régulation de la protéine semblable à un récepteur de la somatostatine humaine |
Country Status (1)
Country | Link |
---|---|
WO (2) | WO2003004530A1 (fr) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999037679A1 (fr) * | 1998-01-26 | 1999-07-29 | Millennium Pharmaceuticals, Inc. | Recepteurs de ligands et leurs utilisations |
WO2000064942A1 (fr) * | 1999-04-27 | 2000-11-02 | Smithkline Beecham Corporation | Axor-27, recepteur couple a une proteine g |
WO2001012673A1 (fr) * | 1999-08-17 | 2001-02-22 | Merck Patent Gmbh | Polypeptides pgpcr-3 et leurs sequences d'adn |
WO2001036473A2 (fr) * | 1999-11-16 | 2001-05-25 | Pharmacia & Upjohn Company | Recepteurs couples a une proteine g |
WO2001036471A2 (fr) * | 1999-11-17 | 2001-05-25 | Arena Pharmaceuticals, Inc. | Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine |
WO2001042288A2 (fr) * | 1999-12-10 | 2001-06-14 | Incyte Genomics, Inc. | Recepteurs couples a la proteine g |
WO2001048188A1 (fr) * | 1999-12-28 | 2001-07-05 | Helix Research Institute | Nouveaux recepteurs couples a la proteine de liaison a guanosine triphosphate, leurs genes, leur preparation et leur utilisation |
WO2001068848A2 (fr) * | 2000-03-01 | 2001-09-20 | Genentech, Inc. | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
WO2001090189A2 (fr) * | 2000-05-24 | 2001-11-29 | Akzo Nobel N.V. | Gene org3 du recepteur couple a une proteine g |
-
2001
- 2001-07-06 WO PCT/EP2001/007737 patent/WO2003004530A1/fr active Application Filing
-
2002
- 2002-07-08 WO PCT/EP2002/007564 patent/WO2003004531A2/fr not_active Application Discontinuation
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999037679A1 (fr) * | 1998-01-26 | 1999-07-29 | Millennium Pharmaceuticals, Inc. | Recepteurs de ligands et leurs utilisations |
WO2000064942A1 (fr) * | 1999-04-27 | 2000-11-02 | Smithkline Beecham Corporation | Axor-27, recepteur couple a une proteine g |
WO2001012673A1 (fr) * | 1999-08-17 | 2001-02-22 | Merck Patent Gmbh | Polypeptides pgpcr-3 et leurs sequences d'adn |
WO2001036473A2 (fr) * | 1999-11-16 | 2001-05-25 | Pharmacia & Upjohn Company | Recepteurs couples a une proteine g |
WO2001036471A2 (fr) * | 1999-11-17 | 2001-05-25 | Arena Pharmaceuticals, Inc. | Versions endogenes et non-endogenes de recepteurs couples a la proteine g humaine |
WO2001042288A2 (fr) * | 1999-12-10 | 2001-06-14 | Incyte Genomics, Inc. | Recepteurs couples a la proteine g |
WO2001048188A1 (fr) * | 1999-12-28 | 2001-07-05 | Helix Research Institute | Nouveaux recepteurs couples a la proteine de liaison a guanosine triphosphate, leurs genes, leur preparation et leur utilisation |
WO2001068848A2 (fr) * | 2000-03-01 | 2001-09-20 | Genentech, Inc. | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides |
WO2001090189A2 (fr) * | 2000-05-24 | 2001-11-29 | Akzo Nobel N.V. | Gene org3 du recepteur couple a une proteine g |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Section Ch Week 200145, Derwent World Patents Index; Class B04, AN 2001-425662, XP002190613 * |
LEE D K ET AL: "Discovery and mapping of ten novel G protein-coupled receptor genes", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 275, no. 1, 5 September 2001 (2001-09-05), pages 83 - 91, XP004307114, ISSN: 0378-1119 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003004531A2 (fr) | 2003-01-16 |
WO2003004530A1 (fr) | 2003-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003284891A1 (en) | A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same | |
AU2003255612A8 (en) | Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments | |
WO2002008392A3 (fr) | Regulation de la serine protease humaine semblable a matriptase | |
WO2003004531A3 (fr) | Regulation d'une proteine du type recepteur de la somatostatine humaine | |
WO2002072824A3 (fr) | Regulation du canal potentiel humain du recepteur transitoire humain | |
WO2002058724A3 (fr) | Utilisation de lp82 pour traiter les problemes de poids | |
WO2004089982A3 (fr) | Variantes april et leurs procedes | |
WO2001077149A3 (fr) | Regulation d'une proteine gpcr type cyslt2 humaine | |
WO2002055694A3 (fr) | Polynucleotides et polypeptides de genes metaboliques et leurs utilisations | |
WO2002036613A3 (fr) | Regulation de la proteine humaine de type 'patched' | |
WO2002062974A3 (fr) | Regulation de la proteine humaine elongase hselo1 | |
WO2002088362A3 (fr) | Regulation d'une proteine semblable a la prostaglandine-f synthase 1 humaine | |
WO2002032938A3 (fr) | Regulation de la proteine humaine de type pgc-1 | |
WO2003025174A3 (fr) | Regulation de la proteine humaine de type mrp1 | |
AU2001292326A1 (en) | Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like | |
EP1383871A4 (fr) | Proteines enzymatiques humaines isolees, molecules d'acides nucleiques codant pour ces proteines, et leurs utilisations | |
WO2002062975A3 (fr) | Regulation de la proteine humaine du type elongase hselo1 | |
WO2002046403A3 (fr) | Regulation de la proteine humaine du type 'patched' | |
EP1385991A4 (fr) | Proteines enzymatiques humaines isolees, molecules d'acide nucleique codant lesdites proteines et utilisations associees | |
EP1383908A4 (fr) | Proteines enzymatiques humaines isolees, molecules d'acides nucleiques codant des proteines enzymatiques humaines et utilisations de celles-ci | |
EP1383877A4 (fr) | Proteines enzymatiques humaines isolees, molecules d'acides nucleiques codant des proteines enzymatiques humaines, et utilisations associees | |
WO2002053749A3 (fr) | Regulation de la proteine kinase serine/threonine humaine | |
WO2003000903A3 (fr) | Regulation de serine/threonine proteine kinase humaine de type nek | |
WO2002046402A3 (fr) | Regulation de la proteine humaine de type 'patched' | |
EE200000631A (et) | Inimese BMP-4 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudaine uurimiseks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |